Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation.

Jun 12, 2026Healthcare (Basel, Switzerland)

Early experiences using psilocybin therapy to support cancer patients receiving palliative care

AI simplified

Abstract

After one year, no patients had received psilocybin-assisted therapy (PAT) in a real-world setting.

  • Perceived clinical relevance and institutional leadership may facilitate the adoption of PAT.
  • Key barriers include administrative and regulatory procedures, as well as logistical constraints related to treatment delivery.
  • Ten professionals from clinical and managerial roles provided insights during semi-structured interviews.
  • The estimated cost of delivering PAT ranges from 2648 to 5827 Canadian dollars (CAD) per patient, excluding the cost of psilocybin.
  • There is a significant gap between regulatory authorization and effective service uptake for PAT.

AI simplified

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free